Global Cellular Immunotherapy Market
The global Cellular Immunotherapy Market was valued at USD 7.5 billion in 2021 which expected to reach USD 37.97 billion by 2027 at a CAGR 22.41% from 2020-2027.
The Qualiket Research offers in-depth analysis, revenue details, and other important information regarding the Cellular Immunotherapy Market, and the various trends, drivers, restraints. A top-down & bottom-up approaches were employed in the preparation of the report on Cellular Immunotherapy Market. The overall report has been sectioned into an overview of the Cellular Immunotherapy Market, segmental outline, regional analysis, competitive dashboard, and the recent market updates. The Cellular Immunotherapy Market overview has been categorized into market statistics as well as the market highlights. Proficient analysts applied modern research methodologies for extensive primary & secondary research on the Cellular Immunotherapy Market.
The market statistics segment briefs on the forecasted CAGR the Cellular Immunotherapy Market is anticipated to register over the review period and the valuation it can attain by the end year. The market highlights details boosters and restraints, which can influence the target market growth over the forecast period. Skilled market analysts have meticulously worked on the evolution of the Cellular Immunotherapy Market and have identified the recent trends reinforcing the Cellular Immunotherapy Market growth. They have also spotted every opportunity based on that the market can capitalize
The market overview was noted on a zero-deviation approach & have maintained excellent quality research techniques throughout the Cellular Immunotherapy Market analysis. The segmental outline targets facets of the Cellular Immunotherapy Market. The regional analysis of the Cellular Immunotherapy Market provides an idea regarding the regional progress of the Cellular Immunotherapy Market as well as the identification of growth windows. In addition, the key vendors of the Cellular Immunotherapy Market have been segregated on a regional basis. Interviews with key people of the Cellular Immunotherapy Market and other credible sources like whitepaper are referred for designing the key operating players section. Furthermore, finally, the Cellular Immunotherapy Market update section mentions the recent key developments in the Cellular Immunotherapy Market
The report also helps in understanding Cellular Immunotherapy Market dynamics, structure by analyzing the market segments and projects the Cellular Immunotherapy Market. Overall representation of competitive analysis of key operating players by financial position, Product portfolio, growth strategies, as well as the regional presence in the Cellular Immunotherapy Market make the report investor’s guide.
Key Players:
The key players profiled in the Leavening Agents market report Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc. (Kite Pharma); F. Hoffmann-La Roche Ltd; Merck KGaA; GlaxoSmithKline plc.; AstraZeneca; Pfizer Inc.; Johnson & Johnson; Celyad, Adicet Bio, Inc.;
Market Taxonomy
By Therapy Type
By Indication
By Region
Global Cellular Immunotherapy Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Cellular Immunotherapy Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Cellular Immunotherapy Market, By Therapy Type
5.1 Y-o-Y Growth Comparison, By Therapy Type
5.2 Global Cellular Immunotherapy Market Share Analysis, By Therapy Type
5.3 Global Cellular Immunotherapy Market Size and Forecast, By Therapy Type
5.3.1 CAR T Cell Therapy
5.3.2 Dendritic Cell Therapy
5.3.3 NK Cell Therapy
5.3.4 TIL Therapy
5.3.5 Others
6 Global Cellular Immunotherapy Market, By Indication
6.1 Y-o-Y Growth Comparison, By Indication
6.2 Global Cellular Immunotherapy Market Share Analysis, By Indication
6.3 Global Cellular Immunotherapy Market Size and Forecast, By Indication
6.3.1 B-cell Malignancies
6.3.2 Prostate Cancer
6.3.3 Liver Cancer
6.3.4 Renal Cell Carcinoma
6.3.5 Others
7 Global Cellular Immunotherapy Market, By End-use
7.1 Y-o-Y Growth Comparison, By End-use
7.2 Global Cellular Immunotherapy Market Share Analysis, By End-use
7.3 Global Cellular Immunotherapy Market Size and Forecast, By End-use
7.3.1 Hospitals
7.3.2 Cancer Institutes
7.3.3 Others
8 Global Cellular Immunotherapy Market, By Region
8.1 Global Cellular Immunotherapy Market Share Analysis, By Region
8.2 Global Cellular Immunotherapy Market Share Analysis, By Region
8.3 Global Cellular Immunotherapy Market Size and Forecast, By Region
9 North America Cellular Immunotherapy Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Cellular Immunotherapy Market Share Analysis, By Therapy Type
9.3 North America Cellular Immunotherapy Market Size and Forecast, By Indication
9.4 North America Cellular Immunotherapy Market Size and Forecast, By End-use
9.6 North America Cellular Immunotherapy Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe Cellular Immunotherapy Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Cellular Immunotherapy Market Share Analysis, By Therapy Type
10.3 Europe Cellular Immunotherapy Market Size and Forecast, By Indication
10.4 Europe Cellular Immunotherapy Market Size and Forecast, By End-use
10.6 Europe Cellular Immunotherapy Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific Cellular Immunotherapy Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Cellular Immunotherapy Market Share Analysis, By Therapy Type
11.3 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By Indication
11.4 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By End-use
11.6 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America Cellular Immunotherapy Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Cellular Immunotherapy Market Share Analysis, By Therapy Type
12.3 Latin America Cellular Immunotherapy Market Size and Forecast, By Indication
12.4 Latin America Cellular Immunotherapy Market Size and Forecast, By End-use
12.6 Latin America Cellular Immunotherapy Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East Cellular Immunotherapy Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Cellular Immunotherapy Market Share Analysis, By Therapy Type
13.3 Middle East Cellular Immunotherapy Market Size and Forecast, By Indication
13.4 Middle East Cellular Immunotherapy Market Size and Forecast, By End-use
13.6 Middle East Cellular Immunotherapy Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Bristol-Myers Squibb Company
15.1.1 Overview
15.1.2 Therapy Types
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Novartis AG
15.2.1 Overview
15.2.2 Therapy Types
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Gilead Sciences Inc
15.3.1 Overview
15.3.2 Therapy Types
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 F. Hoffmann-La Roche Ltd
15.4.1 Overview
15.4.2 Therapy Types
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Merck KGaA
15.5.1 Overview
15.5.2 Therapy Types
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 GlaxoSmithKline plc
15.6.1 Overview
15.6.2 Therapy Types
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 AstraZeneca
15.7.1 Overview
15.7.2 Therapy Types
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Pfizer Inc
15.8.1 Overview
15.8.2 Therapy Types
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Johnson & Johnson
15.9.1 Overview
15.9.2 Therapy Types
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Celyad, Adicet Bio, Inc
15.10.1 Overview
15.10.2 Therapy Types
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
